Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 8 |
| 1.1 List of Tables | 6 | 3 |
| 1.2 List of Figures | 9 | 1 |
| 2 Introduction | 10 | 1 |
| 2.1 Ophthalmic Imaging Equipment Overview | 10 | 1 |
| 3 Products under Development | 11 | 6 |
| 3.1 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development | 11 | 1 |
| 3.2 Ophthalmic Imaging Equipment - Pipeline Products by Segment | 12 | 1 |
| 3.3 Ophthalmic Imaging Equipment - Pipeline Products by Territory | 13 | 1 |
| 3.4 Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path | 14 | 1 |
| 3.5 Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date | 15 | 1 |
| 3.6 Ophthalmic Imaging Equipment - Ongoing Clinical Trials | 16 | 1 |
| 4 Ophthalmic Imaging Equipment - Pipeline Products under Development by Companies | 17 | 4 |
| 4.1 Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development | 17 | 2 |
| 4.2 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development | 19 | 2 |
| 5 Ophthalmic Imaging Equipment Companies and Product Overview | 21 | 55 |
| 5.1 Aeon Imaging, LLC Company Overview | 21 | 1 |
| 5.1.1 Aeon Imaging, LLC Pipeline Products &Ongoing Clinical Trials Overview | 21 | 1 |
| 5.2 Aeon Scientific AG Company Overview | 22 | 1 |
| 5.2.1 Aeon Scientific AG Pipeline Products &Ongoing Clinical Trials Overview | 22 | 1 |
| 5.3 ArcScan, Inc. Company Overview | 23 | 1 |
| 5.3.1 ArcScan, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 23 | 3 |
| 5.4 Ben-Gurion University of the Negev Company Overview | 26 | 1 |
| 5.4.1 Ben-Gurion University of the Negev Pipeline Products &Ongoing Clinical Trials Overview | 26 | 1 |
| 5.5 Brien Holden Vision Institute Company Overview | 27 | 1 |
| 5.5.1 Brien Holden Vision Institute Pipeline Products &Ongoing Clinical Trials Overview | 27 | 1 |
| 5.6 CW Optics, Inc. Company Overview | 28 | 1 |
| 5.6.1 CW Optics, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 28 | 1 |
| 5.7 Dalhousie University Company Overview | 29 | 1 |
| 5.7.1 Dalhousie University Pipeline Products &Ongoing Clinical Trials Overview | 29 | 1 |
| 5.8 Exploit Technologies Pte Ltd Company Overview | 30 | 1 |
| 5.8.1 Exploit Technologies Pte Ltd Pipeline Products &Ongoing Clinical Trials Overview | 30 | 1 |
| 5.9 Eye Marker Systems, Inc. Company Overview | 31 | 1 |
| 5.9.1 Eye Marker Systems, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 31 | 1 |
| 5.10 Eye Tech Care SA Company Overview | 32 | 1 |
| 5.10.1 Eye Tech Care SA Pipeline Products &Ongoing Clinical Trials Overview | 32 | 3 |
| 5.11 Gemss Co.,Ltd. Company Overview | 35 | 1 |
| 5.11.1 Gemss Co.,Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 35 | 1 |
| 5.12 George Washington University Company Overview | 36 | 1 |
| 5.12.1 George Washington University Pipeline Products &Ongoing Clinical Trials Overview | 36 | 1 |
| 5.13 Massachusetts Eye and Ear Infirmary Company Overview | 37 | 1 |
| 5.13.1 Massachusetts Eye and Ear Infirmary Pipeline Products &Ongoing Clinical Trials Overview | 37 | 1 |
| 5.14 Moorfields Eye Hospital NHS Foundation Trust Company Overview | 38 | 1 |
| 5.14.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products &Ongoing Clinical Trials Overview | 38 | 3 |
| 5.15 Next Dimension Ltd. Company Overview | 41 | 1 |
| 5.15.1 Next Dimension Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 41 | 1 |
| 5.16 OcuSciences, Inc. Company Overview | 42 | 1 |
| 5.16.1 OcuSciences, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 42 | 1 |
| 5.17 Ocutronics, LLC Company Overview | 43 | 1 |
| 5.17.1 Ocutronics, LLC Pipeline Products &Ongoing Clinical Trials Overview | 43 | 1 |
| 5.18 Ohio State University Company Overview | 44 | 1 |
| 5.18.1 Ohio State University Pipeline Products &Ongoing Clinical Trials Overview | 44 | 1 |
| 5.19 Optos Plc Company Overview | 45 | 1 |
| 5.19.1 Optos Plc Pipeline Products &Ongoing Clinical Trials Overview | 45 | 5 |
| 5.20 PCAsso Diagnostics LLC Company Overview | 50 | 1 |
| 5.20.1 PCAsso Diagnostics LLC Pipeline Products &Ongoing Clinical Trials Overview | 50 | 1 |
| 5.21 Praevium Research Inc. Company Overview | 51 | 1 |
| 5.21.1 Praevium Research Inc. Pipeline Products &Ongoing Clinical Trials Overview | 51 | 1 |
| 5.22 Predictek, Inc. Company Overview | 52 | 1 |
| 5.22.1 Predictek, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 52 | 1 |
| 5.23 Rensselaer Polytechnic Institute Company Overview | 53 | 1 |
| 5.23.1 Rensselaer Polytechnic Institute Pipeline Products &Ongoing Clinical Trials Overview | 53 | 1 |
| 5.24 RetiVue, LLC Company Overview | 54 | 1 |
| 5.24.1 RetiVue, LLC Pipeline Products &Ongoing Clinical Trials Overview | 54 | 1 |
| 5.25 Ti-TaMed (PTY) LTD. Company Overview | 55 | 1 |
| 5.25.1 Ti-TaMed (PTY) LTD. Pipeline Products &Ongoing Clinical Trials Overview | 55 | 1 |
| 5.26 Tufts University Company Overview | 56 | 1 |
| 5.26.1 Tufts University Pipeline Products &Ongoing Clinical Trials Overview | 56 | 1 |
| 5.27 Universite de Montreal Company Overview | 57 | 1 |
| 5.27.1 Universite de Montreal Pipeline Products &Ongoing Clinical Trials Overview | 57 | 2 |
| 5.28 University College London Company Overview | 59 | 1 |
| 5.28.1 University College London Pipeline Products &Ongoing Clinical Trials Overview | 59 | 2 |
| 5.29 University of Arizona Company Overview | 61 | 1 |
| 5.29.1 University of Arizona Pipeline Products &Ongoing Clinical Trials Overview | 61 | 1 |
| 5.30 University of California, Los Angeles Company Overview | 62 | 1 |
| 5.30.1 University of California, Los Angeles Pipeline Products &Ongoing Clinical Trials Overview | 62 | 2 |
| 5.31 University of Colorado Company Overview | 64 | 1 |
| 5.31.1 University of Colorado Pipeline Products &Ongoing Clinical Trials Overview | 64 | 1 |
| 5.32 University of South Florida Company Overview | 65 | 1 |
| 5.32.1 University of South Florida Pipeline Products &Ongoing Clinical Trials Overview | 65 | 1 |
| 5.33 University of Valencia Company Overview | 66 | 1 |
| 5.33.1 University of Valencia Pipeline Products &Ongoing Clinical Trials Overview | 66 | 1 |
| 5.34 Vision Instruments Pty. Ltd. Company Overview | 67 | 1 |
| 5.34.1 Vision Instruments Pty. Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 67 | 1 |
| 5.35 VisionQuest Biomedical, LLC Company Overview | 68 | 1 |
| 5.35.1 VisionQuest Biomedical, LLC Pipeline Products &Ongoing Clinical Trials Overview | 68 | 5 |
| 5.36 Visual Pathways, Inc. (Inactive) Company Overview | 73 | 1 |
| 5.36.1 Visual Pathways, Inc. (Inactive) Pipeline Products &Ongoing Clinical Trials Overview | 73 | 3 |
| 6 Ophthalmic Imaging Equipment- Recent Developments | 76 | 32 |
| 6.1 Nov 07, 2016: Molecular Partners Announces Management Change | 76 | 1 |
| 6.2 Nov 02, 2016: NOVADAQ Reports Third Quarter 2016 Financial Results | 76 | 1 |
| 6.3 Oct 27, 2016: Molecular Partners: Quarterly Management Statement For The Period Ending September 30, 2016 | 77 | 2 |
| 6.4 Oct 27, 2016: ContextVision Presents Q3 2016 Financial Report | 79 | 1 |
| 6.5 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer | 80 | 1 |
| 6.6 Oct 11, 2016: DigiSight Technologies Showcases State-of-the-Art Paxos Scope Mobile Imaging Solution At AAO 2016 | 81 | 1 |
| 6.7 Sep 28, 2016: Hill-Rom Adding More Than 100 Jobs In Central New York | 81 | 1 |
| 6.8 Sep 12, 2016: Canon U.S.A. to Display Eyecare Devices and Solutions at Vision Expo West | 82 | 1 |
| 6.9 Sep 09, 2016: KKR Invests USD66 Million in AcuFocus | 83 | 1 |
| 6.10 Sep 01, 2016: Molecular Partners reports unaudited half-year results for 2016: A period of continued progress for Molecular Partners | 83 | 2 |
| 6.11 Aug 18, 2016: ContextVision presents Q2 2016 financial report | 85 | 1 |
| 6.12 Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery | 86 | 1 |
| 6.13 Aug 08, 2016: TearScience Names Edward J. Holland, MD to Board of Directors | 87 | 1 |
| 6.14 Aug 02, 2016: MCW Researchers Lead Imaging Study of Patients with Genetic Color Vision Disorder in Advance of AGTC Gene Therapy Clinical Trials | 88 | 1 |
| 6.15 Jul 27, 2016: NOVADAQ Reports Second Quarter 2016 Financial Results | 88 | 1 |
| 6.16 Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization | 89 | 1 |
| 6.17 Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board | 90 | 1 |
| 6.18 Jul 13, 2016: CoxHealth brings diabetic digital retinal imaging to its patients | 90 | 1 |
| 6.19 Jul 06, 2016: Natus Medical Acquires RetCam Ophthalmic Imaging Systems from Clarity Medical Systems for USD10.6 Million | 90 | 1 |
| 6.20 Jul 06, 2016: NOVADAQ Announces Appointment of Rick Mangat as President and CEO | 90 | 1 |
| 6.21 Jun 24, 2016: AcuFocus Raises USD1.9 Million in Venture Financing | 91 | 1 |
| 6.22 May 16, 2016: Escalon Medical Reports Third Quarter Fiscal 2016 Results | 91 | 1 |
| 6.23 May 11, 2016: Carl Zeiss Meditec Records Revenue Growth of 8.6 Percent | 92 | 1 |
| 6.24 May 11, 2016: Nephros Reports First Quarter 2016 Financial Results | 93 | 1 |
| 6.25 May 05, 2016: TearScience Introduces LipiScan For Rapid High Definition Meibomian Imaging | 94 | 1 |
| 6.26 May 02, 2016: Large UK National Health Services (NHS) Study Finds EyeArt Device To Be the Most Sensitive Automated Retinal Image Analysis Technology for Diabetic Retinopathy Screening | 94 | 1 |
| 6.27 Apr 29, 2016: Bausch + Lomb Highlights Scientific and Clinical Research during the Association for Research in Vision and Ophthalmology Annual Meeting in Seattle, WA | 95 | 1 |
| 6.28 Apr 28, 2016: Quarterly Management Statement For The Period Ending March 31, 2016 | 96 | 2 |
| 6.29 Apr 14, 2016: ArcScan receives CE Mark Approval for Its Insight 100 device enabling commercialization across Europe | 98 | 1 |
| 6.30 Apr 13, 2016: Molecular Partners Raises USD31.7 Million in Private Placement of Shares | 98 | 1 |
| 6.31 Apr 12, 2016: iSTAR Medical Raises USD11.4 Million in Series B Financing | 99 | 1 |
| 6.32 Mar 22, 2016: Breakthrough Handheld Technology from Welch Allyn Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings | 99 | 1 |
| 6.33 Mar 17, 2016: AcuFocus Raises USD4 Million in Financing | 99 | 1 |
| 6.34 Feb 29, 2016: Canon U.S.A. Showcases Solutions and Services that can Help Healthcare Providers Achieve a More Complete EHR Strategy at HIMSS 2016 | 100 | 1 |
| 6.35 Feb 16, 2016: Escalon Medical Reports Second Quarter Fiscal 2016 Results | 101 | 1 |
| 6.36 Feb 04, 2016: Molecular Partners reports unaudited financial results for 2015 | 101 | 3 |
| 6.37 Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund | 104 | 1 |
| 6.38 Jan 24, 2016: Fallas Family Vision of McDonough, Georgia, Adds OptoMap Retinal System for an Ultra-Wide View of the Retina During Eye Exams | 105 | 1 |
| 6.39 Jan 15, 2016: Remidio Innovative Solutions Raises Funds in Series B Financing | 106 | 1 |
| 6.40 Jan 11, 2016: Bausch + Lomb Announces 2016 Elite Vendor Relationship with Vision Source | 106 | 1 |
| 6.41 Dec 10, 2015: Molecular Partners received a European Small and Mid-Cap Award | 106 | 1 |
| 6.42 Dec 03, 2015: ArcScan Finalizes US Food and Drug Administration Submission for Its Insight 100 Ophthalmic Medical Device | 107 | 1 |
| 7 Appendix | 108 | 4 |
| 7.1 Methodology | 108 | 3 |
| 7.2 About GlobalData | 111 | 1 |
| 7.3 Contact Us | 111 | 1 |
| 7.4 Disclaimer | 111 | 1 |
